Close

Maravai LifeSciences (MRVI) Tops Q1 EPS by 4c

May 10, 2021 4:20 PM EDT

Maravai LifeSciences (NASDAQ: MRVI) reported Q1 EPS of $0.24, $0.04 better than the analyst estimate of $0.20. Revenue for the quarter came in at $148.2 million versus the consensus estimate of $138.49 million.

GUIDANCE:

Maravai LifeSciences sees FY2021 EPS of $1.04-$1.12, versus the consensus of $0.89. Maravai LifeSciences sees FY2021 revenue of $680-720 million, versus the consensus of $610.97 million.

For earnings history and earnings-related data on Maravai LifeSciences (MRVI) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings, Guidance

Related Entities

Earnings